Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Dec;92(12):3187-3193.
doi: 10.1002/jmv.25756. Epub 2020 Jul 11.

Adenovirus infection among pediatric patients with cancer and in pediatric recipients of hematopoietic stem cell: A multicenter nationwide study

O Zając-Spychała  1 , A Pieczonka  1 , J Wachowiak  1 , J Frączkiewicz  2 , M Salamonowicz  2 , K Kałwak  2 , E Gorczyńska  2 , B Kazanowska  2 , G Wróbel  2 , A Chybicka  2 , K Czyżewski  3 , M Dziedzic  3 , M Wysocki  3 , P Zalas-Więcek  4 , A Szmydki-Baran  5 , Ł Hutnik  5 , M Matysiak  5 , N Irga-Jaworska  6 , E Bień  6 , E Drożyńska  6 , W Stolpa  7 , G Sobol-Milejska  7 , F Pierlejewski  8 , W Młynarski  8 , O Gryniewicz-Kwiatkowska  9 , A Gietka  9 , B Dembowska-Bagińska  9 , K Semczuk  10 , K Dzierżanowska-Fangrat  10 , Z Gamrot-Pyka  11 , M Woszczyk  11 , A Urbanek-Dądela  12 , G Karolczyk  12 , M Płonowski  13 , M Krawczuk-Rybak  13 , A Zaucha-Prażmo  14 , J Kowalczyk  14 , J Goździk  15 , J Styczyński  3
Affiliations
Multicenter Study

Adenovirus infection among pediatric patients with cancer and in pediatric recipients of hematopoietic stem cell: A multicenter nationwide study

O Zając-Spychała et al. J Med Virol. 2020 Dec.

Abstract

The aim was to evaluate the incidence, clinical course, and outcome of adenoviral infection (AdVI) in pediatric patients diagnosed and treated due to cancer and in pediatric recipients of hematopoietic stem cell. Over a 72-month period, all-in 5599 children with cancer: 2441 patients with hematological malignancy (HM) and 3158 with solid tumors (ST), and 971 patients after transplantation: 741 after allogeneic (allo-HSCT) and 230 after autologous (auto-HSCT) were enrolled into the study. Among cancer patients, 67 episodes of AdVI appeared in 63 (1.1%) children, including 45 (1.8%) with HM and 18 (0.6%; P < .001) with ST. Within transplanted patients, AdVIs were responsible for 88 episodes in 81 (8.3%) children (P < .001), including 78 (10.5%) patients after allo-HSCT and 3 (1.3%) after auto-HSCT. Time to develop AdVI was short, especially after allo-HSCT. The most common clinical manifestation in cancer patients was enteritis diagnosed in 63 (94.0%) cases, while among HSCT recipient asymptomatic adenoviremia was found in 36 (40.9%) cases and the most common clinical manifestation was urinary tract infection. Cancer patients with disseminated disease, as well as HSCT recipients with either asymptomatic viremia or disseminated disease, received antiviral treatment. The most commonly used first-line therapy was cidofovir. None of the cancer patients died due to AdVI, while within HSCT recipients three patients developed disseminated adenoviral disease and died despite antiviral treatment. In cancer patients, AdVIs are rare and associated with very good prognosis even without specific treatment. However, in allo-HSCT recipients, disseminated disease with fatal outcome is more likely to occur.

Keywords: adenovirus; cancer; children; hematopoietic stem cell transplantation.

PubMed Disclaimer

References

REFERENCES

    1. McMillen T, Lee YJ, Kamboj M, Babady NE. Limited diagnostic value of a multiplexed gastrointestinal pathogen panel for the detection of adenovirus infection in an oncology patient population. J Clin Virol. 2017;94:37-41.
    1. Renzi S, Ali S, Portwine C, et al. Adenovirus infection in children with acute myeloid leukemia: a report from the Canadian infection in Acute Myeloid Leukemia Research Group. Pediatr Infect Dis J. 2018;37(2):135-137.
    1. Lion T. Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev. 2014;27(3):441-462.
    1. Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis. 2012;14(6):555-563.
    1. Grimley MS, Chemaly RF, Englund JA, et al. Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial. Biol Blood Marrow Transplant. 2017;23(3):512-521.

Publication types

Substances

LinkOut - more resources